Skip to content
GLP-1 Savers
Menu

Head-to-head · Value Score

bmiMD vs MedLeanRx

Two GLP-1 deals, scored on the same six factors. bmiMD lands a Value Score of 89, MedLeanRx a 71. Here's who gives you the honest lower price — and where each one bites back.

★ Better value

bmiMD

#11 · Grade A · Great Deal

Est. first month

$99/mo

Save ~93% vs brand-name
Get this deal Full bmiMD review →
VS

MedLeanRx

#226 · Grade C · Watch List

Est. first month

From $149/mo (starting dose, compounded)

Save ~89% vs brand-name
Get this deal Full MedLeanRx review →

The verdict

Better value: bmiMD

bmiMD takes it on Value Score, 89 to 71 an est. $99/mo first month, with no teaser step-up baked in. MedLeanRx isn't out of it: Shoppers who want texas-only compounded semaglutide at $149/mo with a brand Wegovy and Zepbound pathway.

Our #1 overall:Neither of these is our top pick — that's CoreAge Rx (Value Score 93).See why →

Deal-by-deal

The numbers that decide it. Green ✓ marks the stronger side on each line.

DealbmiMDMedLeanRx
Value Score89 (A)71 (C)
Est. first month$99/moFrom $149/mo (starting dose, compounded)
Save vs brand-name~93%~89%
Semaglutide$99/moFrom $149/mo (starting dose, compounded)
Tirzepatide$139/moFrom $269/mo (starting dose, compounded)
Both moleculesYesYes
PricingFlat — no step-upWatch
CoverageAll 50 states1 states

Factor by factor

The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.

95
Lowest Real Price
82
bmiMD: 95. MedLeanRx: 82.
84
No Teaser-Rate Bait
64
bmiMD: 84. MedLeanRx: 64.
98
Nationwide Availability
40
bmiMD: 98. MedLeanRx: 40.
94
Both Molecules
98
bmiMD: 94. MedLeanRx: 98.
82
Easy Cancellation
58
bmiMD: 82. MedLeanRx: 58.
70
Reputation
68
bmiMD: 70. MedLeanRx: 68.

bmiMD

Sub-$100 semaglutide and a low $139 tirzepatide, flat and nationwide — a straight-up low-price play.

Why it's a deal

  • $99 flat semaglutide and a low $139 tirzepatide
  • Available in all 50 states
  • Both molecules priced up front

The fine print

  • Not LegitScript-certified — do your own pharmacy diligence
  • Thin public track record; no oral or brand-name option

MedLeanRx

MedLeanRx is a physician-guided telehealth weight-loss clinic serving Texas only, based in Spring, TX.

Why it's a deal

  • Compounded semaglutide $149/mo in both weekly injection and daily oral tablet form
  • Brand pathway for Wegovy, Zepbound, and Foundayo (orforglipron) at a $99/mo fee plus medication cost
  • Intro bundle: 2 months of compounded tirzepatide (2 mg weekly) for $325 — about $163/mo
  • LegitScript seal displayed; named supervising physician (Dr. Johnson Uzor, MD)
  • Free shipping, no hidden fees, and cancel-anytime plans per homepage trust chips

The fine print

  • Texas only — not available in the other 49 states
  • Compounded tirzepatide is $269/mo at standard pricing, above the ~$249 market median
  • Strict no-refund policy: 'All sales are final' per Terms & Conditions
  • Pharmacy partner not publicly named — a transparency gap for a compounding service
  • Legal entity name and founding details not published on the site
Get the bmiMD deal Get the MedLeanRx deal

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.

Neither one the right fit? Every program that outscores bmiMD is ranked on the bmiMD alternatives board, and the same list for the other side is on alternatives to MedLeanRx.

More head-to-heads

← All comparisons

Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.